•
Jun 30, 2023

Selecta Biosciences Q2 2023 Earnings Report

Total Revenue
$5.25M
Previous year: $39.3M
-86.6%
EPS
-$0.07
Previous year: $0.06
-216.7%
Gross Profit
$11.2M
Previous year: $39.3M
-71.5%
Cash and Equivalents
$112M
Previous year: $138M
-18.9%
Free Cash Flow
-$9.91M
Previous year: -$12.4M
-19.9%
Total Assets
$140M
Previous year: $188M
-25.8%

Selecta Biosciences

Selecta Biosciences